BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silva-Costa C, Brito MJ, Pinho MD, Friães A, Aguiar SI, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections., Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015. Emerg Infect Dis 2018;24:1307-14. [PMID: 29912700 DOI: 10.3201/eid2407.180029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Li MC, Wang Y, Zhang H, Liu Y, Chen XJ, Yang HW, Ma P, Wang DC, Zhang BC, Dong AY, Wang CX, Li Y, Bai P, Tang WM, Wang J, Shao ZJ, Xu YC. Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Hum Vaccin Immunother 2021;17:146-56. [PMID: 32530720 DOI: 10.1080/21645515.2020.1757996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Díaz‐conradi A, Hernández S, García‐garcía JJ, Muñoz‐almagro C, Moraga‐llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, González‐peris S, Uriona S, Martínez‐osorio J, Solé‐ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Domínguez A. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era. Pediatr Pulmonol 2019;54:517-24. [DOI: 10.1002/ppul.24279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
3 Hiller NL, Sá-Leão R. Puzzling Over the Pneumococcal Pangenome. Front Microbiol 2018;9:2580. [PMID: 30425695 DOI: 10.3389/fmicb.2018.02580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Wantuch PL, Avci FY. Invasive pneumococcal disease in relation to vaccine type serotypes. Hum Vaccin Immunother 2019;15:874-5. [PMID: 30668209 DOI: 10.1080/21645515.2018.1564444] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
5 Yang Y, Hua CZ, Fang C, Xie YP, Li W, Fu Y, Gao F, Yao KH. Properties of Mucoid Serotype 3 Streptococcus pneumoniae From Children in China. Front Cell Infect Microbiol 2021;11:648040. [PMID: 33842394 DOI: 10.3389/fcimb.2021.648040] [Reference Citation Analysis]
6 González-peris S, Campins M, García-garcía JJ, Díaz-conradi Á, Domínguez Á, Ciruela P, de Sevilla MF, Hernández S, Muñoz-almagro C, Izquierdo C, Codina G, Uriona S, Esteva C, Solé-ribalta A, Soldevila N, Planes AM, Martínez-osorio J, Salleras L, Moraga-llop F. Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain. Enfermedades Infecciosas y Microbiología Clínica 2020. [DOI: 10.1016/j.eimc.2020.08.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 [DOI: 10.1101/409359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Scott NR, Mann B, Tuomanen EI, Orihuela CJ. Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines. Vaccines (Basel) 2021;9:209. [PMID: 33801372 DOI: 10.3390/vaccines9030209] [Reference Citation Analysis]
9 Akbar N, Kawish M, Jabri T, Khan NA, Shah MR, Siddiqui R. Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles. Pathog Glob Health 2021;:1-17. [PMID: 34937524 DOI: 10.1080/20477724.2021.2014235] [Reference Citation Analysis]
10 Abu Seir R, Azmi K, Hamdan A, Namouz H, Jaar F, Jaber H, Rubin C, Doron D, Rahav G, Abdeen Z, Regev-Yochay G. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). PLoS One 2018;13:e0206927. [PMID: 30418989 DOI: 10.1371/journal.pone.0206927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kawaguchiya M, Urushibara N, Aung MS, Habadera S, Ito M, Kudo K, Kobayashi N. Association Between Pneumococcal Surface Protein A Family and Genetic/Antimicrobial Resistance Traits of Non-Invasive Pneumococcal Isolates from Adults in Northern Japan. Microb Drug Resist 2019;25:744-51. [PMID: 30676875 DOI: 10.1089/mdr.2018.0267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ozkaya-Parlakay A, Polat M, Gulhan B, Kanik-Yuksek S, Tezer H, Nar-Otgun S. Pediatric cases caused by Streptococcus pneumoniae Serotype 3. Hum Vaccin Immunother 2019;15:873. [PMID: 30582728 DOI: 10.1080/21645515.2018.1554975] [Reference Citation Analysis]
13 Dagan R. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation. Expert Rev Vaccines 2019;18:641-61. [PMID: 31230486 DOI: 10.1080/14760584.2019.1627207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
14 Alarcón ZK, Duarte C, Sanabria O, Moreno J. Streptococcus pneumoniae serotype 3 genotypes in invasive isolates from Colombia. Biomedica 2021;41:338-46. [PMID: 34214273 DOI: 10.7705/biomedica.5407] [Reference Citation Analysis]
15 de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. The Lancet 2020;396:786-98. [DOI: 10.1016/s0140-6736(20)31550-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
16 Silva-Costa C, Brito MJ, Aguiar SI, Lopes JP, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections., Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012-2015). Sci Rep 2019;9:6. [PMID: 30626918 DOI: 10.1038/s41598-018-36799-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
17 Hu T, Weiss T, Bencina G, Owusu-Edusei K, Petigara T. Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries. J Med Econ 2021;24:1098-107. [PMID: 34461796 DOI: 10.1080/13696998.2021.1970975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Goettler D, Streng A, Kemmling D, Schoen C, von Kries R, Rose MA, van der Linden M, Liese JG. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Vaccine 2020;38:570-7. [PMID: 31735502 DOI: 10.1016/j.vaccine.2019.10.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
19 Almeida ST, Paulo AC, Froes F, de Lencastre H, Sá-Leão R. Dynamics of Pneumococcal Carriage in Adults: A New Look at an Old Paradigm. J Infect Dis 2021;223:1590-600. [PMID: 32877517 DOI: 10.1093/infdis/jiaa558] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Coronas E, Martinot A, Varon E, Wallet F, Dubos F; Hospital Network for Evaluating the Management of Common Childhood Diseases. Stable Incidence of Invasive Pneumococcal Disease in Children in Northern France From 2014 Through 2018. Pediatr Infect Dis J 2021;40:688-93. [PMID: 34097661 DOI: 10.1097/INF.0000000000003095] [Reference Citation Analysis]
21 Lodi L, Ricci S, Nieddu F, Moriondo M, Lippi F, Canessa C, Mangone G, Cortimiglia M, Casini A, Lucenteforte E, Indolfi G, Resti M, Azzari C. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children. Vaccines (Basel) 2019;7:E128. [PMID: 31554213 DOI: 10.3390/vaccines7040128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
22 Silva-Costa C, Gomes-Silva J, Prados L, Ramirez M, Melo-Cristino J, On Behalf Of The Portuguese Group For The Study Of Streptococcal Infections, The Portuguese Study Group Of Invasive Pneumococcal Disease Of The Pediatric Infectious Disease Society. Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan-The Continued Importance of Serotype 3. Microorganisms 2021;9:1428. [PMID: 34361864 DOI: 10.3390/microorganisms9071428] [Reference Citation Analysis]
23 Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, Macartney K, Marshall H, Martin AC, McCallum GB, McCullagh A, McDonald T, McIntyre P, Oftadeh S, Ranganathan S, Suresh S, Wainwright CE, Wilson A, Wong M, Snelling T, Jaffé A. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax 2021;76:487-93. [PMID: 33504566 DOI: 10.1136/thoraxjnl-2020-216032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Linley E, Bell A, Gritzfeld JF, Borrow R. Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays? Vaccines (Basel) 2019;7:E4. [PMID: 30609868 DOI: 10.3390/vaccines7010004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
25 Paschall AV, Middleton DR, Wantuch PL, Avci FY. Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase. Pharm Res 2020;37:236. [PMID: 33140159 DOI: 10.1007/s11095-020-02960-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Zimmermann P, Perrett KP, Berbers G, Curtis N. Persistence of pneumococcal antibodies after primary immunisation with a polysaccharide-protein conjugate vaccine. Arch Dis Child 2019;104:680-4. [PMID: 30796020 DOI: 10.1136/archdischild-2018-316254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Ozdilek A, Huang J, Babb R, Paschall AV, Middleton DR, Duke JA, Pirofski LA, Mousa JJ, Avci FY. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies. mBio 2021;12:e0080021. [PMID: 34061603 DOI: 10.1128/mBio.00800-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Hernández S, Moraga-Llop F, Díaz A, de Sevilla MF, Ciruela P, Muñoz-Almagro C, Codina G, Campins M, García-García JJ, Esteva C, Izquierdo C, González-Peris S, Martínez-Osorio J, Uriona S, Salleras L, Domínguez Á. Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain. Emerg Infect Dis 2020;26:1147-55. [PMID: 32441620 DOI: 10.3201/eid2606.190951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
29 Luck JN, Tettelin H, Orihuela CJ. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front Cell Infect Microbiol 2020;10:613287. [PMID: 33425786 DOI: 10.3389/fcimb.2020.613287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Valdivielso Martínez AI, Ramos Fernández JM, Pérez Frías J, Moreno Pérez D. Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia. Int J Infect Dis 2020;98:194-9. [PMID: 32553718 DOI: 10.1016/j.ijid.2020.06.034] [Reference Citation Analysis]
31 Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F, Dommergues MA, Mezgueldi E, Levieux K, Béchet S, Varon E, Cohen R; Pneumonia Study Group ., GPIP (Pediatric Infectious Disease Group) . Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. J Pediatric Infect Dis Soc 2019;8:474-7. [PMID: 30407519 DOI: 10.1093/jpids/piy103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
32 Agudelo CI, Castañeda-Orjuela C, Brandileone MCC, Echániz-Aviles G, Almeida SCG, Carnalla-Barajas MN, Regueira M, Fossati S, Alarcón P, Araya P, Duarte C, Sánchez J, Novas M, Toraño-Peraza G, Rodríguez-Ortega M, Chamorro-Cortesi G, Kawabata A, García-Gabarrot G, Camou T, Spadola E, Payares D, Andrade AL, Di Fabio JL, Castañeda E; SIREVA Working Group. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study. Lancet Infect Dis 2021;21:405-17. [PMID: 32986996 DOI: 10.1016/S1473-3099(20)30489-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
33 Forstner C, Kolditz M, Kesselmeier M, Ewig S, Rohde G, Barten-Neiner G, Rupp J, Witzenrath M, Welte T, Pletz MW; CAPNETZ study group. Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia. Vaccine 2020;38:1129-36. [PMID: 31761500 DOI: 10.1016/j.vaccine.2019.11.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
34 Echániz-Aviles G, Guerreiro SI, Silva-Costa C, Mendes CI, Carriço JA, Carnalla-Barajas MN, Soto-Noguerón A, Velazquez-Meza ME, Melo-Cristino J, Luévanos-Velazquez A, Martínez-Medina L, Vázquez-Larios MDR, Ramirez M. Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction. J Clin Microbiol 2019;57:e01354-18. [PMID: 30404945 DOI: 10.1128/JCM.01354-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M, Diaz-Conradi A, Marti C, Motje M, Galles C, Morta M, Izquierdo C, Moraga-Llop F, Campins M, Salleras L, Jane M, Dominguez A, Garcia-Garcia JJ, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One 2020;15:e0228612. [PMID: 32027715 DOI: 10.1371/journal.pone.0228612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
36 Redin A, Ciruela P, de Sevilla MF, Gomez-Bertomeu F, Gonzalez-Peris S, Benitez MA, Trujillo G, Diaz A, Jou E, Izquierdo C, Perez-Moreno MO, Moraga-Llop F, Olsina M, Vinado B, Sanfeliu E, Garcia A, Gonzalez-di Lauro S, Garcia-Garcia JJ, Dominguez A, Sa-Leao R, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Microbiol Spectr 2021;9:e0115021. [PMID: 34878302 DOI: 10.1128/Spectrum.01150-21] [Reference Citation Analysis]
37 Ziv O, Kraus M, Holcberg R, Dinur AB, Kordeluk S, Kaplan D, Rosenblatt HN, Ben-Shimol S, Greenberg D, Leibovitz E. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines. Int J Pediatr Otorhinolaryngol 2019;119:123-30. [PMID: 30703661 DOI: 10.1016/j.ijporl.2019.01.031] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Carloni I, Ricci S, Rubino C, Cobellis G, Rinaldelli G, Azzari C, de Benedictis FM. Necrotizing pneumonia among Italian children in the pneumococcal conjugate vaccine era. Pediatr Pulmonol 2021;56:1127-35. [PMID: 33442941 DOI: 10.1002/ppul.25270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Levy C, Varon E, Ouldali N, Wollner A, Thollot F, Corrard F, Werner A, Béchet S, Bonacorsi S, Cohen R. Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine. PLoS One 2019;14:e0211712. [PMID: 30707730 DOI: 10.1371/journal.pone.0211712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]